首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In Vivo Emergence of Multidrug-Resistant Mutants of Pseudomonas aeruginosa Overexpressing the Active Efflux System MexA-MexB-OprM
【2h】

In Vivo Emergence of Multidrug-Resistant Mutants of Pseudomonas aeruginosa Overexpressing the Active Efflux System MexA-MexB-OprM

机译:铜绿假单胞菌的多药耐药突变体的体内出现过表达主动外排系统MexA-MexB-OprM

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During a 6-month period, 21 pairs of Pseudomonas aeruginosa isolates susceptible (pretherapy) and resistant (posttherapy) to antipseudomonal β-lactam antibiotics were isolated from hospitalized patients. In vivo emergence of β-lactam resistance was associated with the overexpression of AmpC β-lactamase in 10 patients. In the other 11 patients, the posttherapy isolates produced only low, basal levels of β-lactamase and had increased levels of resistance to a variety of non-β-lactam antibiotics (e.g., quinolones, tetracyclines, and trimethoprim) compared with the levels of β-lactamase production and resistance of their pretherapy counterparts. These data suggested the involvement of the MexA-MexB-OprM active efflux system in the multidrug resistance phenotype of the posttherapy strains. Immunoblotting of the outer membrane proteins of these 11 bacterial pairs with a specific polyclonal antibody raised against OprM demonstrated the overexpression of OprM in all the posttherapy isolates. To determine whether mutations in mexR, the regulator gene of the mexA-mexB-oprM efflux operon, could account for the overproduction of the efflux system, sequencing experiments were carried out with the 11 bacterial pairs. Eight posttherapy isolates were found to contain insertions or deletions that led to frameshifts in the coding sequences of mexR. Two resistant strains had point mutations in mexR that yielded single amino acid changes in the protein MexR, while another strain did not show any mutation in mexR or in the promoter region upstream of mexR. Introduction of a plasmid-encoded wild-type mexR gene into five posttherapy isolates partially restored the susceptibility of the bacteria to selected antibiotics. These results indicate that in the course of antimicrobial therapy multidrug-resistant active efflux mutants overexpressing the MexA-MexB-OprM system may emerge as a result of mutations in the mexR gene.
机译:在6个月的时间里,从住院患者中分离出21对铜绿假单胞菌分离株,它们对抗假性β-内酰胺类抗生素敏感(治疗前)和耐药性(治疗后)。 10位患者体内出现β-内酰胺抗性与AmpCβ-内酰胺酶的过表达有关。与其他11例患者相比,治疗后分离株仅产生较低的基础β-内酰胺酶基础水平,并且对多种非β-内酰胺类抗生素(例如,喹诺酮,四环素和甲氧苄氨嘧啶)的抗药性水平增加。 β-内酰胺酶的产生和抗药性与治疗前相当。这些数据表明,MexA-MexB-OprM主动外排系统参与了治疗后菌株的多药耐药表型。用针对OprM的特异性多克隆抗体对这11个细菌对的外膜蛋白进行免疫印迹,证明在所有治疗后分离株中OprM均过表达。为了确定mexA-mexB-oprM外排操纵子的调节基因mexR中的突变是否可以解释外排系统的过度生产,对11个细菌对进行了测序实验。发现八种治疗后分离株含有导致mexR编码序列移码的插入或缺失。两种抗性菌株在mexR中具有点突变,可在蛋白质MexR中产生单个氨基酸变化,而另一种菌株在mexR或mexR上游的启动子区域中未显示任何突变。将质粒编码的野生型mexR基因导入五个治疗后的分离株中,部分恢复了细菌对所选抗生素的敏感性。这些结果表明,在抗微生物治疗的过程中,过表达MexA-MexB-OprM系统的多药耐药活性外排突变体可能是mexR基因突变的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号